JAX Event Presentations

Use of Humanized Mouse Models in Drug Development - Voot Yin

The Next Generation of Humanized Mice for Biomedical Research - Mike Brehm

Humanized FLT3 Mice with full Hematopoietic Repertoire... - Patricia Resa-Infante

Advances In Vitro and In Vivo Strategies for the Evaluation of Antibody-Drug Conjugates for Oncology - Lenka Kyrych Sadilkova, PhD

Exploring Humanised Mouse Models to Evaluate Immunotherapeutic... - Melanie Galvin

Humanized FcRn mouse model for evaluating PK, allometric scaling and more! - Michael Kiffe

JAX and Authera Focus on FcRn biology - Simone Mester - 2024 EU Workshop Series

A Novel PBMC Humanized Mouse - James Keck - 2024 EU Workshop Series

Use of Humanized Mouse Models in Drug Development - Brian Soper - 2024 EU Workshop Series

The first comparative study of different lymphoma targeting ADCs in Humanized Mice - Tibor Schomber - 2024 EU Workshop Series

Application of Humanized Mice for Therapeutic Target Validation - Ali Roghenian - 2024 EU Workshop Series

HuPK™ Highlights for EU Symposium

Humanized Mice Highlights for EU Symposium

CRS Highlights for EU Symposium

Using the Hu-PK Platform to Predict the PK of Candidate Therapeutic Antibodies

Innovative Humanized In Vivo Models to Evaluate Iatrogenic Cytokine Release Syndrome

How to Use Humanized Models to Test the Efficacy of Immunotherapies

In vivo Preclinical Efficacy & Safety of CAR-T, -NK, and -Myeloid Based Therapies

Evaluation of Safety and Efficacy of Antibody-based and CAR T Therapies in PBMC Humanized Mice

Presented by Jiwon Yang, Ph.D. - Senior Scientist, Innovation and Product Development, The Jackson Laboratory